Jpmorgan Chase & CO Sera Prognostics, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 884,867 shares of SERA stock, worth $7.19 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
884,867
Previous 11,865
7357.79%
Holding current value
$7.19 Million
Previous $70,000
9758.57%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SERA
# of Institutions
64Shares Held
20.3MCall Options Held
120KPut Options Held
0-
Baker Bros. Advisors LP New York, NY5.43MShares$44.2 Million0.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.03MShares$24.7 Million0.33% of portfolio
-
Interwest Venture Management CO2.42MShares$19.6 Million21.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$13.4 Million1.88% of portfolio
-
Black Rock Inc. New York, NY1.41MShares$11.5 Million0.0% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $241M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...